Peptide Drugs intermediate
GLP-1 and NAFLD
Clinical evidence for efficacy in nonalcoholic fatty liver disease including steatosis reduction.
By Encyclopeptide Editorial | 1 min read
glp1 nafld liver
GLP-1 and NAFLD
Overview
Clinical evidence for efficacy in nonalcoholic fatty liver disease including steatosis reduction.
Structure
| Property | Value |
|---|---|
| Name | GLP-1 and NAFLD |
Mechanism of Action
Hepatic GLP-1 receptor effects reduce lipogenesis and promote fatty acid oxidation.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 and NAFLD |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about GLP-1 and NAFLD with interactive quizzes on Wikipept.
Take a Quiz on Wikipept